Therefore, we suggest that DNA methylation of ALDH1A2 and the expression of ALDH1A2 might serve as reliable markers for the early diagnosis of disease to improve the outcome for patients with ovarian cancer, considering that an accurate and timely diagnosis is often crucial for treatment selection. The gene discussed is ALDH1A2; the disease is ovarian carcinoma.